| # | Drug | Count |
|---|---|---|
| 0 | DASATINIB | 46 |
| 1 | NILOTINIB | 37 |
| 2 | IMATINIB | 34 |
| 3 | PONATINIB HYDROCHLORIDE | 29 |
| 4 | IMATINIB MESYLATE | 26 |
| 5 | RUXOLITINIB | 18 |
| 6 | ALLOPURINOL | 16 |
| 7 | FUROSEMIDE | 13 |
| 8 | ASCIMINIB | 12 |
| 9 | VENETOCLAX | 12 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PONATINIB HYDROCHLORIDE | 29 | 0.0055 |
| 1 | DASATINIB | 46 | 0.0050 |
| 2 | ASCIMINIB | 12 | 0.0034 |
| 3 | NELARABINE | 2 | 0.0021 |
| 4 | SEVELAMER HYDROCHLORIDE | 1 | 0.0017 |
| 5 | NILOTINIB | 37 | 0.0013 |
| 6 | IMATINIB MESYLATE | 26 | 0.0009 |
| 7 | OMEPRAZOLE 20MG | 1 | 0.0009 |
| 8 | ARSENIC TRIOXIDE | 2 | 0.0009 |
| 9 | ANAGRELIDE HYDROCHLORIDE | 1 | 0.0009 |
| # | Drug class | Count |
|---|---|---|
| 0 | Kinase Inhibitor [EPC] | 34 |
| 1 | Corticosteroid [EPC] | 22 |
| 2 | Janus Kinase Inhibitor [EPC] | 18 |
| 3 | Xanthine Oxidase Inhibitor [EPC] | 16 |
| 4 | Loop Diuretic [EPC] | 13 |
| 5 | Nucleoside Metabolic Inhibitor [EPC] | 13 |
| 6 | BCL-2 Inhibitor [EPC] | 12 |
| 7 | Antimetabolite [EPC] | 9 |
| 8 | Azole Antifungal [EPC] | 9 |
| 9 | beta-Adrenergic Blocker [EPC] | 7 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interferon alfa-2b [EPC] | 1 | 0.0005 |
| 1 | Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] | 1 | 0.0003 |
| 2 | Antimalarial [EPC] | 3 | 0.0003 |
| 3 | Antiprotozoal [EPC] | 3 | 0.0003 |
| 4 | Antihypoglycemic Agent [EPC] | 1 | 0.0002 |
| 5 | BCL-2 Inhibitor [EPC] | 12 | 0.0002 |
| 6 | Sulfone [EPC] | 2 | 0.0002 |
| 7 | Interleukin-1 Receptor Antagonist [EPC] | 3 | 0.0002 |
| 8 | Iron Chelator [EPC] | 4 | 0.0001 |
| 9 | Janus Kinase Inhibitor [EPC] | 18 | 0.0001 |